Coeptis Therapeutics Stock Net Asset
| COEP Stock | USD 10.90 0.31 2.93% |
Coeptis Therapeutics fundamentals help investors to digest information that contributes to Coeptis Therapeutics' financial success or failures. It also enables traders to predict the movement of Coeptis Stock. The fundamental analysis module provides a way to measure Coeptis Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Coeptis Therapeutics stock.
Coeptis | Net Asset |
Coeptis Therapeutics Company Net Asset Analysis
Coeptis Therapeutics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Coeptis Therapeutics Net Asset | 4.57 M |
Most of Coeptis Therapeutics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Coeptis Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Coeptis Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Coeptis Therapeutics is extremely important. It helps to project a fair market value of Coeptis Stock properly, considering its historical fundamentals such as Net Asset. Since Coeptis Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Coeptis Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Coeptis Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Coeptis Total Assets
Total Assets |
|
Based on the recorded statements, Coeptis Therapeutics has a Net Asset of 4.57 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Coeptis Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Coeptis Therapeutics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Coeptis Therapeutics could also be used in its relative valuation, which is a method of valuing Coeptis Therapeutics by comparing valuation metrics of similar companies.Coeptis Therapeutics is currently under evaluation in net asset category among its peers.
Coeptis Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Coeptis Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Coeptis Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Coeptis Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Coeptis Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Coeptis Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Coeptis Therapeutics' value.| Shares | Commonwealth Equity Services Inc | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 0.0 | Arista Wealth Management Llc | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-12-31 | 0.0 | Geode Capital Management, Llc | 2024-12-31 | 0.0 | Meteora Capital, Llc | 2024-12-31 | 0.0 | Virtu Financial Llc | 2024-09-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-09-30 | 0.0 | Cambridge Invest Research Advisors, Inc. | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 6.8 K | Mint Tower Capital Management B.v. | 2024-12-31 | 2.2 K |
Coeptis Fundamentals
| Return On Equity | -14.81 | ||||
| Return On Asset | -1.87 | ||||
| Current Valuation | 34.98 M | ||||
| Shares Outstanding | 39.72 M | ||||
| Shares Owned By Insiders | 18.53 % | ||||
| Shares Owned By Institutions | 4.05 % | ||||
| Number Of Shares Shorted | 13.84 K | ||||
| Price To Book | 7.12 X | ||||
| Price To Sales | 45.68 X | ||||
| Gross Profit | 75 K | ||||
| EBITDA | (20.16 M) | ||||
| Net Income | (21.27 M) | ||||
| Cash And Equivalents | 2.38 M | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 1.22 M | ||||
| Debt To Equity | 1.89 % | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (7.24 M) | ||||
| Short Ratio | 0.40 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Target Price | 3.0 | ||||
| Beta | -0.94 | ||||
| Market Capitalization | 8.06 M | ||||
| Total Asset | 4.57 M | ||||
| Retained Earnings | (87.36 M) | ||||
| Working Capital | 2.26 M | ||||
| Net Asset | 4.57 M |
About Coeptis Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coeptis Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coeptis Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coeptis Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Coeptis Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coeptis Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Coeptis Stock
Moving against Coeptis Stock
| 0.9 | PEPG | PepGen | PairCorr |
| 0.86 | ZURA | Zura Bio Limited | PairCorr |
| 0.86 | MLTX | MoonLake Immunotherapeuti | PairCorr |
| 0.84 | MLYS | Mineralys Therapeutics, Trending | PairCorr |
| 0.74 | PMVP | Pmv Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Coeptis Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coeptis Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coeptis Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coeptis Therapeutics to buy it.
The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coeptis Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coeptis Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coeptis Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.